These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8708659)

  • 1. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
    Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caudate hyperintensities in elderly depressed patients with neuroleptic-induced parkinsonism.
    Figiel GS; Krishnan KR; Doraiswamy PM; Nemeroff CB
    J Geriatr Psychiatry Neurol; 1991; 4(2):86-9. PubMed ID: 1677248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic-induced Parkinsonism: Clinicopathological study.
    Shuaib UA; Rajput AH; Robinson CA; Rajput A
    Mov Disord; 2016 Mar; 31(3):360-5. PubMed ID: 26660063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in drug-induced parkinsonism.
    Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S
    Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced Parkinson`s disease. A clinical review.
    Bohlega SA; Al-Foghom NB
    Neurosciences (Riyadh); 2013 Jul; 18(3):215-21. PubMed ID: 23887211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
    Dhopesh V; Macfadden A; Maany I; Gamble G
    Psychiatr Serv; 1997 Jan; 48(1):95-7. PubMed ID: 9117510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early phase II trial with L-deprenyl for the treatment of neuroleptic-induced parkinsonism.
    Perényi A; Bagdy G; Arató M
    Pharmacopsychiatria; 1983 Sep; 16(5):143-6. PubMed ID: 6140692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
    Rajput AH; Rozdilsky B; Hornykiewicz O; Shannak K; Lee T; Seeman P
    Arch Neurol; 1982 Oct; 39(10):644-6. PubMed ID: 6127066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism induced by high doses of diazepam.
    Suranyi-Cadotte BE; Nestoros JN; Nair NP; Lal S; Gauthier S
    Biol Psychiatry; 1985 Apr; 20(4):455-7. PubMed ID: 2858229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.